Company / Return on Assets (ROA)
AXIM BIOTECHNOLOGIES, INC. Return on Assets (ROA) History
FY2011-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-195.6%
FY2023
5-year range
-400.9% / -148.2%
FY2019-FY2023
Trend
-31.9%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) has fluctuated over the past 9 years, ranging from -800.0% in FY2015 to -2.0% in FY2011.
Based on SEC 10-K filings.
-195.6% in FY2023 with a 10-year CAGR of -38.5%.
Improved from -323.3% to -195.6% over the past 5 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- +127.8pp
- 10-Year Change
- -38.5pp
Key checks
Key Insights
- In FY2023, return on assets (roa) decreased 31.9% year-over-year.
- Peak return on assets (roa) was recorded in FY2011.
- Lowest return on assets (roa) in the period was in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -18.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2023 | -195.6% | -31.9% |
| FY2022 | -148.2% | +54.2% |
| FY2018 | -323.3% | -70.0% |
| FY2017 | -190.1% | +52.6% |
| FY2016 | -400.9% | +49.9% |
| FY2015 | -800.0% | -409.5% |
| FY2013 | -157.0% | -1299.4% |
| FY2012 | -11.2% | -452.7% |
| FY2011 | -2.0% | - |
As of FY2023 · SEC 10-K · Updated Jun 29, 2026